Indications and uses
dries the oozing and weeping o poison ivy, poison oak, and poison sumac.
dries the oozing and weeping o poison ivy, poison oak, and poison sumac.
Adults and children 2 years of age and older: shake well before using. Cleanse the skin with soap and water and dry the area before application. Apply lotion to the affected area using cotton or soft cloth, as often as needed for comfort. Children under 2 years of age: Consult a doctor before use.
Drug Facts
Calamine 8% and Zinc Oxide 8%
Skin protectant
dries the oozing and weeping o poison ivy, poison oak, and poison sumac.
For external use only. Use only as directed.
Avoid contact with eyes and mucous membranes.
Discontinue use if condition worsens or does not improve within 7 days and consult a doctor.
In case of accidental ingestion, seek professional assistance or contact a Poison Control center immediately.
Adults and children 2 years of age and older: shake well before using. Cleanse the skin with soap and water and dry the area before application. Apply lotion to the affected area using cotton or soft cloth, as often as needed for comfort.
Children under 2 years of age: Consult a doctor before use.
Store at room temperature 13-30C (50-86F)
Bentonite magma, calcium hydroxide, carrageenan, glycerin, microcrystalline cellulose, purified water, and xanthan gum.
| Class | Version | Type | Effective |
|---|---|---|---|
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0303950413969 | GTIN-13: 0303950413969 EAN-13: 0303950413969 GTIN-12: 303950413969 UPC-A: 303950413969 GTIN storage (14 digits): 00303950413969 | Humco Calamine 5 26 2026.jpg, capture.jpg |
| QR code link | QR Code | capture.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0395-0413-96 | Humco Calamine | 177 mL in 1 BOTTLE, PLASTIC | LOTION | 177 | 8 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0395-0413-96 | ML - Milliliter | 0395-0413 | 7388d9e7-558f-47b8-9386-b0372be86ab3 | 1 | 2014-04-03 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| CALCIUM HYDROXIDE | INACTIVE INGREDIENT | PF5DZW74VN | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0395-0413 | 0395-0413-96 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENTONITE | A3N5ZCN45C | IACT |
| CARRAGEENAN | 5C69YCD2YJ | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| CALCIUM HYDROXIDE | PF5DZW74VN | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| ZINC OXIDE | SOI2LOH54Z | ACTIM |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Humco Calamine | CALAMINE 8% AND ZINC OXIDE 8% | Humco holding Group, Inc. | f7dcd959-fb98-43bb-8dd3-a662bf8a053c | 2026-05-26 | Warnings | 0395-0413-96 0395-0413 00395041396 52b9f60d-7ae7-26c8-e063-6294a90acc20 f7dcd959-fb98-43bb-8dd3-a662bf8a053c |
Adverse event summaries are temporarily unavailable. Other product information remains available.